ASP Isotopes to acquire Renergen via share exchange valued at ~$110M

ASP Isotopes Inc.

ASPI to issue 0.09196 shares per Renergen share; Renergen holders will own ~16% of combined company.
Transaction valued at ~$110M based on ASPI closing price on May 21, 2025.
Closing conditions: lender consents (IDC, DFC, SBSA), SA regulatory approvals, Renergen shareholder vote.
ASPI advanced $10M loan to Renergen with commitment for up to $30M; loan repayment risks if deal fails.
Pro forma financial statements of Renergen and combined entity filed with this 8-K.

item 8.01item 2.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.